Cultural Foundation
Author:
enVVeno Medical Corporation
enVVeno Medical Discusses FDA IDE Approval in Virtual Investor “What This Means” Segment
May 12, 2026
enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System
May 7, 2026
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve
April 29, 2026
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System
March 27, 2026